The prevalence of animal diseases, disorders and illnesses has put the spotlight on veterinary medicines. Farmers and pet owners bank on drugs to keep their animal disease free and healthy. The medicine can also be used to control and monitor zoonotic diseases and maintain livestock food supply. Veterinarians also work in agribusiness to ensure a safe food supply, while also helping farmers boost their productivity.
The rising allergic disease among dogs has prompted industry leaders to inject funds into research and development programs and product rollouts. In January 2022, Zoetis announced European Commission marketing authorization for Apoquel chewable tablets for dogs. It will help treat pruritus and provide enough time for veterinarians to identify the cause of allergic disease in dogs. The database lists dogs as the most represented targeted species (65%).
The huge repository of Grand View Research includes competitive insights exhibiting forward-looking companies’ strategic approaches to bolster their market penetration in veterinary medicine. For instance, in 2021, the top four animal health products in Boehringer Ingelheim led to net sales of more than EUR 1,894 million. The final report, along with the database, will deep-dive into the following dynamics:
- Insights on molecules/active ingredients, including Lokivetmab, maleate, Amoxicillin, Selamectin, Pyrantel and Ivermectin.
- Inputs on regulatory approvals, patent information, ASP and competition from generics, among others.
- Analysis of a diverse portfolio of diagnose products and veterinary medicines. For instance, pharmaceuticals (most represented in the database) account for 72% share of the total products.
- Assessment of anti-inflammatory, antiparasitic, antibiotics and dermatology products.
Get your copy or request a free sample of the report “50 Key Veterinary Medicines with Estimated Sales, 2018 – 2022,” collated and published by Grand View Research.
Key Veterinary Medicine Report Scope
|Brand name||Marketed name of the Product e.g., Simparica/Simparica Trio|
|INN||Name of the Active Ingredient or Generic Name. The database includes Oclacitinib maleate, Lokivetmab, Selamectin, Amoxicillin, Ivermectin, Pyrantel, and others.|
|Molecular Weight||Weight of each active ingredient molecule in grams per mole (g/mol)|
|Company||Name of the Company manufacturing/ marketing the Product. The database includes leading animal health companies such as Zoetis, Virbac, Elanco, and Boehringer Ingelheim International GmbH|
|First Approval/ Launch Year||The year that indicates the first ever launch of the product. For example, Apoquel was first launched in 2014 by Zoetis. Note: Most of the products in the database have been launched between 2000 and 2015|
|Indication||Specifies approved uses of the product. For instance, the database includes products indicated for dermatitis, pain, osteoarthritis, parasitic diseases, bacterial infections, etc.|
|Type||Specifies the type of the product such as Pharmaceuticals/ Vaccines/ Medicated Feed Additives|
|Category||Specifies the category or sub-type of the product such as antiparasitic, antibiotic, anti-inflammatory, and dermatology. Anti-infective products such as antiparasitics, and antibiotics are the most dominant in the database.|
|Dosage Form||The database includes dosage forms such as injectables, tablets, sprays, and collars, among others.|
|Target Species||Dogs dominate the database in terms of target species while others include cats and cattle.|
|Estimated Sales||Specifies global revenue of the product in USD million from 2018 to 2022. The highest revenue generated by a product in 2021 was estimated at about USD 750 million.|
|ASP (in USD)||Average Selling Price per unit in line with the dosage form|
|Commercialized/ Available in||Regions/ countries where the product is sold|
|Patent/ Generics Information||Qualitative information about patents, patent expiry, and generics is provided as per the availability of information. For instance, the patents covering the commercial formulation of a product in the database expire in the U.S. in October 2023 and in Brazil in 2025.|
|Other Notes||Any other relevant information about the product or any recent initiative covering the product launch, upgrade, etc. For instance, Apoquel by Zoetis is the first Janus kinase inhibitor approved for use in veterinary medicine.|
|Deliverable Format||MS Excel/ Dashboard|
Get more insights from our in-depth market intelligence report “Veterinary Medicine Market Size, Share & Trends Analysis Report By Animal Type (Production Animals, Companion Animals), By Product (Biologics, Pharmaceuticals), By Mode Of Delivery, By End-use, By Region, And Segment Forecasts, 2023 – 2030”
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports